Grants and Contributions:
Title:
Design and Development of Point of Care Device for Heart Function Monitoring
Agreement Number:
917425
Agreement Value:
$545,000.00
Agreement Date:
Dec 1, 2018 - Mar 31, 2021
Description:
The objective of this project is to design and develop a bedside/at home cardiac biomarker-based technology and device to achieve better outcomes for patients living with Heart Failure. CardiAi's POC development plan includes the development of a disposable cardiac biomarker sensor based testing strip and a small format hand held electronic reader.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Calgary, Alberta, CA T1Y 0B4
Reference Number:
172-2018-2019-Q3-917425
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
782397517
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days. Calgary Forest Lawn 48006
Amendment Date
Dec 15, 2020
Recipient's Operating Name:
CardiAI Inc.
Recipient's Legal Name:
CardiAI Inc.
Federal Riding Name:
Calgary Skyview
Federal Riding Number:
48013
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
62151
Amendments: